Kolexia
Cordel Hugues
Maladies infectieuses
Hôpital Avicenne
Bobigny, France
74 Activités
209 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tuberculose Infections à VIH COVID-19 Tuberculose pulmonaire Maladies transmissibles Tuberculose latente Infections urinaires Abcès Paludisme

Industries

A+A
22 collaboration(s)
Dernière en 2023
ViiV Healthcare
16 collaboration(s)
Dernière en 2023
MSD
8 collaboration(s)
Dernière en 2022
Gilead
7 collaboration(s)
Dernière en 2023

Dernières activités

The French medical community united against cuts to State Medical Aid
Health policy (Amsterdam, Netherlands)   01 mai 2024
BedBiopsy: diagnostic performance of bedside ultrasound-guided bone biopsies for the management of diabetic foot infection.
Diabetes & metabolism   03 mars 2024
Assessing respiratory epidemic potential in French hospitals through collection of close contact data (April-June 2020).
Scientific reports   14 février 2024
Socioeconomic impact of the COVID-19 crisis and early perceptions of COVID-19 vaccines among immigrant and nonimmigrant people living with HIV followed up in public hospitals in Seine-Saint-Denis, France.
PloS one   20 octobre 2023
Mixed outcomes following a third SARS-CoV-2 vaccine dose in previously unresponsive people with HIV.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology   29 novembre 2022
Tuberculosis treatment outcomes among precarious patients in France.
Infectious diseases now   05 septembre 2022
Could travel clinics become priority sites for targeted HIV and hepatitis B screening?
Journal of travel medicine   18 juillet 2022
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study.
BMC infectious diseases   13 juin 2022
Altération de la réponse vaccinale contre la COVID-19 dans l'infection à VIH avancée
Médecine et Maladies Infectieuses Formation   01 juin 2022
Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
AIDS (London, England)   28 février 2022